Volume 19, Number 5—May 2013
Research
Changes in Severity of Influenza A(H1N1)pdm09 Infection from Pandemic to First Postpandemic Season, Germany
Table 1
Characteristic | No. (%) patients |
p value | |
---|---|---|---|
2009–10 | 2009–10 | ||
Total no. admitted patients | 102 | 76 | |
Male sex | 56 (55) | 36 (47) | 0.32 |
Age, mean | 18.2 | 38 | <0.05 |
Days in hospital | 7.6 | 13.9 | <0.05 |
Admitted to ICU | 14 (14) | 35 (46) | <0.05 |
Severely diseased | 15 (15) | 35 (46) | <0.05 |
Died | 5 (5) | 9 (12) | 0.05 |
Pregnant | 4 (4) | 5 (7) | 0.50 |
Pneumonia | 29 (28) | 33 (43) | <0.05 |
Mechanical ventilation | 11 (11) | 24 (32) | <0.05 |
Underlying medical condition | 52 (51) | 57 (75) | <0.05 |
Immunosuppression | 22 (22) | 41 (54) | <0.05 |
Cancer | 2 (2) | 4 (5) | 0.23 |
Blood malignancy | 10 (10) | 15 (20) | 0.06 |
Solid organ transplant | 7 (7) | 14 (18) | <0.05 |
Autoimmune | 5 (5) | 6 (8) | 0.41 |
Other | 2 (2) | 3 (4) | 0.65 |
Chronic lung disease | 9 (9) | 13 (17) | 0.10 |
Cardiovascular disease | 25 (25) | 33 (43) | <0.05 |
Renal impairment | 9 (9) | 20 (26) | <0.05 |
Diabetes | 6 (6) | 11 (14) | 0.05 |
Metabolic dysfunction | 15 (15) | 13 (17) | 0.66 |
Neurologic impairment | 15 (15) | 8 (11) | 0.41 |
CRP level on admission, mg/L† | 34.7 (range <2.0–213.6) | 69.2 (range <2.0–381.4) | <0.05 |
Leukocyte count on admission, /nL† | 9.9 [range 0.1–108.7) | 9.1 (range 0.9–48.8) |
*ICU, intensive care unit; CRP; C-reactive protein.
†Or the following day if not tested on admission.
1These authors contributed equally to this article.
Page created: April 23, 2013
Page updated: April 23, 2013
Page reviewed: April 23, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.